Abstract
The way we assess risk of coronary heart disease has become more accurate in recent years. How does this affect the efficacy of primary and secondary prevention strategies?
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adult
-
Aged
-
Anticholesteremic Agents / therapeutic use
-
Coronary Disease / prevention & control*
-
Health Policy
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hypercholesterolemia / prevention & control
-
Hypertension / prevention & control
-
Middle Aged
-
Risk Assessment
-
Risk Factors
Substances
-
Anticholesteremic Agents
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors